El-Karaksy Hanaa M, El-Raziky Mona S, Fouad Hanan M, Anwar Ghada M, El-Mougy Fatma M, El-Koofy Nehal M, El-Hennawy Ahmad M
Department of Pediatrics, Cairo University, Cairo, Egypt.
Department of Pediatrics, Cairo University, Cairo, Egypt.
Diabetes Metab Syndr. 2015 Apr-Jun;9(2):114-9. doi: 10.1016/j.dsx.2013.10.008. Epub 2013 Nov 14.
The aim of the present study was to determine the association between insulin resistance (IR) and both non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome (MetS) in a group of Egyptian overweight/obese children and adolescents and to evaluate different IR indices in detection of NAFLD.
The study included 76 overweight/obese children aged 2-15 years; 52.6% were males. Laboratory analysis included fasting blood glucose, serum insulin, lipid profile, liver biochemical profile, and liver ultrasound. IR was calculated using the following indices; the homeostasis model assessment method (HOMA-IR), the quantitative insulin-sensitivity check index (QUICKI) and hepatic insulin sensitivity. The National Cholesterol Education Program Adult Treatment Panel III criteria were used to estimate prevalence of MetS. Liver biopsy was done when medically indicated and accepted by parents.
IR was detected in 43.4% and 34.2% by using QUICKI and HOMA, respectively. MetS was detected in 36.8% and NAFLD was detected in 45.5% among those performing liver biopsy. Cases with NAFLD had more frequent IR than children with normal histology. QUICKI showed significant difference between normal subjects and both steatosis and non-alcoholic steatohepatitis; while HOMA-IR was sensitive in cases with NASH only. MetS was present in 100% of patients with NASH and in 75% of those with steatosis and they were all obese. Patients with NASH had significantly higher ALT than those with normal histology.
IR was significantly associated with NAFLD. QUICKI is considered more sensitive than HOMA-IR in differentiating simple steatosis from normal liver histology.
本研究旨在确定一组埃及超重/肥胖儿童及青少年中胰岛素抵抗(IR)与非酒精性脂肪性肝病(NAFLD)及代谢综合征(MetS)之间的关联,并评估不同IR指标在检测NAFLD中的作用。
该研究纳入了76名2至15岁的超重/肥胖儿童;其中52.6%为男性。实验室分析包括空腹血糖、血清胰岛素、血脂谱、肝脏生化指标以及肝脏超声检查。使用以下指标计算IR:稳态模型评估法(HOMA-IR)、定量胰岛素敏感性检查指数(QUICKI)以及肝脏胰岛素敏感性。采用美国国家胆固醇教育计划成人治疗小组第三次报告的标准来评估MetS的患病率。在有医学指征且经家长同意的情况下进行肝脏活检。
分别使用QUICKI和HOMA检测到IR的比例为43.4%和34.2%。在进行肝脏活检的患者中,MetS的检出率为36.8%,NAFLD的检出率为45.5%。与组织学正常的儿童相比,NAFLD患者的IR更为常见。QUICKI在正常受试者与脂肪变性及非酒精性脂肪性肝炎患者之间显示出显著差异;而HOMA-IR仅在非酒精性脂肪性肝炎患者中具有敏感性。100%的非酒精性脂肪性肝炎患者和75%的脂肪变性患者存在MetS,且他们均为肥胖患者。非酒精性脂肪性肝炎患者的谷丙转氨酶(ALT)显著高于组织学正常的患者。
IR与NAFLD显著相关。在区分单纯脂肪变性与正常肝脏组织学方面,QUICKI被认为比HOMA-IR更敏感。